MIRZA SAJID BAIG: Open Payments
NPI 1255591376 · ASHBURN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 7 payments from 4 companies in 2025. Trend: 2023 $151 · 2024 $36 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
Products named: INGREZZA, TRINTELLIX, REXULTI, Jornay PM.
Industry payments across VA — which companies pay providers there.
